Brief: Shield Therapeutics Says FY Group Revenues Ahead Of Expectations At $32.2 Mln

Shield Therapeutics

05/02/2025 07:15

Feb 5 (Reuters) - Shield Therapeutics PLC  STXS.L :
    * SHIELD THERAPEUTICS  - UNAUDITED FULL YEAR TRADING UPDATE
    * SHIELD THERAPEUTICS PLC - FY GROUP REVENUES AHEAD OF
EXPECTATIONS AT $32.2M
    * SHIELD THERAPEUTICS PLC - FY NET SELLING PRICE INCREASES
42% TO
$237 PER PRESCRIPTION
    * SHIELD THERAPEUTICS PLC - EXPECTED TOTAL REVENUES OF
$32.2M FOR
FY24

Source text:  ID:nRSE8925Va 
Further company coverage:  STXS.L 

 ((Reuters.Briefs@thomsonreuters.com;))